Venancio Produtos Farmaceuticos Ltda.
Venancio Produtos Farmaceuticos Ltda., a prominent player in the pharmaceutical industry, is headquartered in Brazil and operates extensively across various regions within the country. Founded in 1990, the company has established itself as a trusted provider of high-quality pharmaceutical products, focusing on both prescription and over-the-counter medications. With a commitment to innovation, Venancio offers a diverse range of core products, including analgesics, anti-inflammatories, and dermatological treatments, all distinguished by their efficacy and safety. The company’s dedication to research and development has led to significant milestones, positioning it as a leader in the Brazilian market. Venancio Produtos Farmaceuticos Ltda. continues to enhance its reputation through a robust portfolio and a focus on customer satisfaction, making it a key contributor to the healthcare landscape in Brazil.
DitchCarbon Score
How does Venancio Produtos Farmaceuticos Ltda.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Venancio Produtos Farmaceuticos Ltda.'s score of 26 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Venancio Produtos Farmaceuticos Ltda.'s reported carbon emissions
Venancio Produtos Farmaceuticos Ltda., headquartered in Brazil, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges from the company, indicating a lack of publicly available commitments towards reducing their carbon footprint. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and climate action, but Venancio's current stance on these issues remains unclear. For stakeholders and environmentally conscious consumers, it is essential to monitor the company's future initiatives and commitments to understand their impact on climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Venancio Produtos Farmaceuticos Ltda. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
